Article info
PDFResearch ethics
Paper
Perceptions of control and unrealistic optimism in early-phase cancer trials
- Correspondence to Dr Lynn A Jansen, Madeline Brill Nelson Chair in Ethics Education, Oregon Health & Science University-Center for Ethics in Health Care, 3181 S.W. Sam Jackson Park Rd, Portland, OR 97239, USA; jansen{at}ohsu.edu
Citation
Perceptions of control and unrealistic optimism in early-phase cancer trials
Publication history
- Received June 2, 2016
- Revised April 25, 2017
- Accepted June 13, 2017
- First published August 3, 2017.
Online issue publication
January 30, 2018
Article Versions
- Previous version (30 January 2018).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Other content recommended for you
- Two concepts of therapeutic optimism
- Understanding people’s ‘unrealistic optimism’ about clinical research participation
- Phase 1 oncology trials and informed consent
- Unrealistic optimism and the ethics of phase I cancer research
- Informed consent for early-phase clinical trials: therapeutic misestimation, unrealistic optimism and appreciation
- Navigating choice in the face of uncertainty: using a theory informed qualitative approach to identifying potential patient barriers and enablers to participating in an early phase chimeric antigen receptor T (CAR-T) cell therapy trial
- Smokers’ unrealistic optimism about their risk
- Effect of research participation versus usual clinical care in patients with rheumatic and musculoskeletal disorders: a prospective cohort study
- Diabetes causal attributions among affected and unaffected individuals
- Psychological contribution to the understanding of adverse events in health care